Recap: Amryt Pharma Q1 Earnings


Amryt Pharma AMYT reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Amryt Pharma missed estimated earnings by 150.0%, reporting an EPS of $-0.05 versus an estimate of $-0.02.

Revenue was up $10.70 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 4.7% drop in the share price the next day.

Here's a look at Amryt Pharma's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.15 -0.17 0.19 0.13
EPS Actual -0.07 -0.07 -0.04 -0.09
Revenue Estimate 56.81M 52.78M 50.49M 46.15M
Revenue Actual 54.83M 56.52M 62.76M 48.43M

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsNewsBZI-Recaps